Compare ACET & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACET | FSI |
|---|---|---|
| Founded | 1947 | 1991 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.3M | 74.3M |
| IPO Year | N/A | 1999 |
| Metric | ACET | FSI |
|---|---|---|
| Price | $8.58 | $6.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $65.33 | N/A |
| AVG Volume (30 Days) | ★ 208.6K | 35.0K |
| Earning Date | 03-05-2026 | 11-14-2025 |
| Dividend Yield | N/A | ★ 1.65% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $38,563,427.00 |
| Revenue This Year | N/A | $7.49 |
| Revenue Next Year | N/A | $53.12 |
| P/E Ratio | ★ N/A | $43.22 |
| Revenue Growth | N/A | ★ 0.18 |
| 52 Week Low | $7.15 | $3.46 |
| 52 Week High | $17.44 | $11.48 |
| Indicator | ACET | FSI |
|---|---|---|
| Relative Strength Index (RSI) | 78.42 | 39.21 |
| Support Level | $7.76 | $6.01 |
| Resistance Level | $8.55 | $6.41 |
| Average True Range (ATR) | 0.45 | 0.35 |
| MACD | -0.14 | -0.02 |
| Stochastic Oscillator | 73.85 | 20.42 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.